भारत न्यूज़: कोरोना महामारी के खिलाफ लड़ाई में वैक्सीन काफी अहम उपाय के रूप में उभरा है। दुनिया के कुछ देशों में कोरोना के खिलाफ बूस्टर डोज की शुरुआत हो चुकी है। जानें देश में बूस्टर डोज को लेकर क्या स्थिति है।
Compulsory Licensing for Covid Vaccines Not an Attractive Option, Tech Transfer is the Key: Paul yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
NEW DELHI: Compulsory licensing for Covid vaccines is not a very attractive option since it is not a formula that matters and other aspects like sourcing of raw materials and training of human resources also need to be taken into consideration, Niti Aayog Member V K Paul said on Thursday.
Paul, the Chair of the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), noted that technology transfer is the key and that remains in the hands of the company that has carried out R&D.
The government has faced criticism from various quarters over the shortage of Covid vaccines amid the country grappling with rising infections.